From dithiocarbamates to branched dithiocarbazates: Compounds with potent antischistosomal activity
Archiv der Pharmazie · 2023-03 · 356 (3)
DOI: 10.1002/ardp.202200491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 08.12.2022. Verfasst von Tom L Gallinger und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Chemistry, Philipps University Marburg, Marburg, Germany. Hauptthemen laut MEDLINE: Schistosomicides, Schistosomiasis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: LOEWE Zentrum DRUID.
Abstract (Originalsprache)
Schistosomiasis or bilharzia is caused by blood flukes of the genus Schistosoma and represents a considerable health and economic burden in tropical and subtropical regions. The treatment of this infectious disease relies on one single drug: praziquantel (PZQ). Therefore, new and potent antischistosomal compounds need to be developed. In our previous work, starting with the drug disulfiram, we developed dithiocarbamates with in vitro antischistosomal activities in the low micromolar range. Based on these results, we report in this study on the synthesis and biological testing of the structurally related dithiocarbazates against Schistosoma mansoni , one of the major species of schistosomes. In total, three series of dithiocarbazate derivatives were examined, and we found that the antischistosomal activity of N ‐unbranched dithiocarbazates increased by further N ‐substitution. Comparable tetra‐substituted dithiocarbazates were rarely described in the literature, thus a synthesis route was established. Due to the elaborate synthesis, the branched dithiocarbazates (containing an N ‐aminopiperazine) were simplified, but the resulting branched dithiocarbamates (containing a 4‐aminopiperidine) were considerably less active. Taken together, dithiocarbazate‐containing compounds with an in vitro antischistosomal activity of 5 µM were obtained.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Chemistry, Philipps University Marburg, Marburg, Germany.
- BFS, Institute of Parasitology, Justus Liebig University Giessen, Giessen, Germany.
Förderung
- LOEWE Zentrum DRUID
Zitieren
APA
Gallinger, T. L., Obermann, W., Lange-Grünweller, K., Schmidt, N., Haeberlein, S., Grünweller, A., Grevelding, C. G., & Schlitzer, M. (2023). From dithiocarbamates to branched dithiocarbazates: Compounds with potent antischistosomal activity. Archiv der Pharmazie, 356(3). https://doi.org/10.1002/ardp.202200491
Vancouver
Gallinger TL, Obermann W, Lange-Grünweller K, Schmidt N, Haeberlein S, Grünweller A, et al. From dithiocarbamates to branched dithiocarbazates: Compounds with potent antischistosomal activity. Archiv der Pharmazie. 2023;356(3). doi:10.1002/ardp.202200491
BibTeX
@article{Gallinger2023,
author = {Gallinger, Tom L and Obermann, Wiebke and Lange-Grünweller, Kerstin and Schmidt, Nina and Haeberlein, Simone and Grünweller, Arnold and Grevelding, Christoph G and Schlitzer, Martin},
title = {From dithiocarbamates to branched dithiocarbazates: Compounds with potent antischistosomal activity},
journal = {Archiv der Pharmazie},
year = {2023},
volume = {356},
number = {3},
doi = {10.1002/ardp.202200491}
}
EUVIMED